Search research articles
Contact Us
Filters
Showing results (311-320 of 430) with videos related to
Page
of 43
Sort By:
Cancer Cell
|
June 13, 2023
Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity
Claire Vennin, Chiara M Cattaneo, Leontien Bosch, et al.
Breast Cancer Research and Treatment
|
May 19, 2022
Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature
M Opdam, V van der Noort, M Kleijn, et al.
Journal of the National Cancer Institute
|
March 17, 2018
Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure
Irene E G van Hellemond, Ingeborg J H Vriens, Petronella G M Peer, et al.
Iscience
|
August 29, 2024
Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial
Mark Opdam, Annelot G J van Rossum, Marlous Hoogstraat, et al.
The British Journal of Surgery
|
April 10, 2024
De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1-2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07)
Sabine R de Wild, Lori M van Roozendaal, Johannes H W de Wilt, et al.
The British Journal of Surgery
|
May 14, 2025
Three-year patient-reported outcomes of the BOOG 2013-08 RCT evaluating omission of sentinel lymph node biopsy in early-stage breast cancer patients treated with breast conserving surgery: Impact of personality traits on health-related quality of life
Veerle M Wintraecken, Lori M van Roozendaal, Janine M Simons, et al.
BMC Medicine
|
January 8, 2024
Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status
Yuwei Wang, Gwen M H E Dackus, Efraim H Rosenberg, et al.
International Journal of Cancer
|
May 18, 2022
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial
Simone N Koole, Philip C Schouten, Jan Hauke, et al.
BMJ Open
|
November 16, 2017
Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study
Gwen Mhe Dackus, Natalie D Ter Hoeve, Mark Opdam, et al.
Nature Cancer
|
April 10, 2023
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial
Leonie Voorwerk, Olga I Isaeva, Hugo M Horlings, et al.
Page
of 43
Search research articles
Search
Showing results (311-320 of 430) with videos related to
Sort By:
Page
of 43
Cancer Cell
|
June 13, 2023
Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicity
Claire Vennin, Chiara M Cattaneo, Leontien Bosch, et al.
Breast Cancer Research and Treatment
|
May 19, 2022
Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature
M Opdam, V van der Noort, M Kleijn, et al.
Journal of the National Cancer Institute
|
March 17, 2018
Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure
Irene E G van Hellemond, Ingeborg J H Vriens, Petronella G M Peer, et al.
Iscience
|
August 29, 2024
Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial
Mark Opdam, Annelot G J van Rossum, Marlous Hoogstraat, et al.
The British Journal of Surgery
|
April 10, 2024
De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1-2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07)
Sabine R de Wild, Lori M van Roozendaal, Johannes H W de Wilt, et al.
The British Journal of Surgery
|
May 14, 2025
Three-year patient-reported outcomes of the BOOG 2013-08 RCT evaluating omission of sentinel lymph node biopsy in early-stage breast cancer patients treated with breast conserving surgery: Impact of personality traits on health-related quality of life
Veerle M Wintraecken, Lori M van Roozendaal, Janine M Simons, et al.
BMC Medicine
|
January 8, 2024
Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status
Yuwei Wang, Gwen M H E Dackus, Efraim H Rosenberg, et al.
International Journal of Cancer
|
May 18, 2022
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial
Simone N Koole, Philip C Schouten, Jan Hauke, et al.
BMJ Open
|
November 16, 2017
Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study
Gwen Mhe Dackus, Natalie D Ter Hoeve, Mark Opdam, et al.
Nature Cancer
|
April 10, 2023
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial
Leonie Voorwerk, Olga I Isaeva, Hugo M Horlings, et al.
Page
of 43